WASHINGTON, Feb. 19 (TNSjou) -- The American College of Cardiology posted the following news release on Feb. 18, 2026: * * * Ancient Mind-Body Practice Proven to Lower Blood Pressure in Clinical Trial Study shows traditional Chinese practice comparable to brisk walking and some medication trials at lowering BP * A traditional Chinese mind-body practice that combines slow, structured movement, deep breathing and meditative focus lowered blood pressure as effectively as brisk walking in a lar more PR

LOS ANGELES, California, Feb. 18 -- The Reason Foundation issued the following news on Feb. 17, 2026: * * * Aviation Policy News: DHS shutdown highlights airport security system's flaws Plus: NTSB collision report cites FAA failures, NASA's obsolete Moon launch program, and more. In this issue: * DHS shutdown highlights airport security system's flaws * NTSB collision report cites FAA failures * "FAA and aviation policy reform: the time is now" * FAA reorganization plan muddies the water more PR

LINCOLN, Nebraska, Feb. 18 -- The University of Nebraska posted the following news: * * * Biography spotlights Virginia Faulkner's legacy at Nebraska Press * A decade ago, the University of Nebraska Press published a list of its 75 most significant books for its 75th anniversary. At number one, above books by Mari Sandoz, Ted Kooser, even Willa Cather -"Roundup: A Nebraska Reader," compiled and edited by Virginia Faulkner in 1957. Notably, the list is in chronological order by publication  more PR

NEW YORK, Feb. 18 [Category: BizHospital] -- NYU Langone Health, an academic medical center affiliated with New York University, posted the following news release: * * * Cancer Stress Protein Helps Tumors Hide from Immunity * A protein made by stressed cancer cells helps lung and pancreatic tumors evade the immune system, a new study shows. Led by NYU Langone Health researchers, the work found that new drugs designed to block the action of a protein called lipocalin 2 (LCN2) slowed cancer  more PR

WASHINGTON, Feb. 19 -- The Center for European Policy Analysis posted the following commentary on Feb. 18, 2026, by Gabrielius Landsbergis, former Minister of Foreign Affairs of Lithuania: * * * Landsbergis: Europe, Look to Thyself If Europe hopes to find inspiration and security from others it is destined for disappointment, says Lithuania's former Foreign Minister Gabrielius Landsbergis. * I left this year's Munich Security Conference in a mood which diplomats would describe as "thoughtfu more PR

LONDON, England, Feb. 18 [Category: Arts/Cultural] -- The Museums Association posted the following news: * * * Earliest ever Youtube video enters V&A collection * A reconstruction of an early YouTube watch page from 2005, featuring the first video ever published on the site, has been acquired by and put on display at the Victoria and Albert Museum's (V&A) South Kensington site. Visitors can now watch YouTube co-founder Jawed Karim's "Me at the zoo" in the V&A's Design 1900-Now gallery. The more PR

NEW YORK, Feb. 18 [Category: Media] -- Fox News Media, a business unit of Fox, posted the following news release: * * * FOX NEWS DIGITAL MARKS BEST MONTH EVER WITH OVER 187 MILLION TOTAL DIGITAL MULTIPLATFORM UNIQUE VISITORS IN JANUARY * FOX News Delivers 14% Year-over-Year Growth Scoring Top-Performing January in History on YouTube Network Continues Dominance Across all News Brands and Broadcast Networks NEW YORK - February 18, 2026 - During January, FOX News Digital delivered its best  more PR

LAWRENCE, Kansas, Feb. 18 -- The University of Kansas posted the following news: * * * Jerry Seib to host new WSJ bipartisan polling team at the Dole Institute, will write new Bob Dole biography * LAWRENCE -The Robert J. Dole Institute of Politics at the University of Kansas has announced Dole Institute Visiting Fellow Jerry Seib will return to the institute this spring to moderate " Inside the Electorate: A Bipartisan Look Ahead to the 2026 Midterms." The event, which will take place at 7 more PR

RALEIGH, North Carolina, Feb. 18 -- The North Carolina Democratic Party issued the following news on Feb. 17, 2026: * * * North Carolina "Shoulder[ing] Billions in Costs" and Bleeding Manufacturing Jobs Thanks To Michael Whatley's Tariffs New reporting from Fox News is highlighting how North Carolina is "bearing the brunt of hefty tariff bills." Whatley's tariffs are "raising prices" and devastating North Carolina's working families and small businesses. This comes as Carolina Journal repor more PR

PHILADELPHIA, Pennsylvania, Feb. 18 -- Temple University posted the following news: * * * New study reveals how to keep readers' attention in digital age New research from Temple's Fox School of Business shows that while headlines are important when it comes to grabbing readers' attention, storytelling design is key when it comes to maintaining it. * Since the dawn of newspapers in the 17th century, journalists' and storytellers' top mechanism for capturing a reader's attention has been th more PR

BASEL, Switzerland, Feb. 19 -- Novartis, a pharmaceutical company, issued the following news release on Feb. 18, 2026: * * * Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU) * Statistically significant and clinically meaningful results seen in RemIND trial with complete responses achieved in 3 CIndU types1 * Remibrutinib, a highly selective oral BTK inhibitor, was well-tolerated and demonstrated a favorable safety profile, inclu more PR

MEMPHIS, Tennessee, Feb. 19 (TNSjou) -- The University of Tennessee Health Science Center issued the following news: * * * Research from UT Health Sciences Adds Insight to FDA Nutrition Label Proposal Written by Lee Ferguson When Yuru Huang, PhD, an assistant professor in the Department of Preventive Medicine at the University of Tennessee Health Science Center, talks about nutrition policy, she doesn't start with statistics or regulatory language. She starts with the grocery store. Picture more PR

RARITAN, New Jersey, Feb. 19 -- Johnson and Johnson Innovative Medicine issued the following news release on Feb. 18, 2026: * * * RYBREVANT FASPRO(TM) (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer New designation is based on data showing rapid and durable responses in a heavily pretreated patient population and expands the promise of RYBREVANT FASPRO(TM) beyond lung cancer * Johnson & Johnson (NYSE:JNJ more PR

CINCINNATI, Ohio, Feb. 19 -- The University of Cincinnati posted the following news: * * * Social media linked to student loneliness National media outlets highlight UC study examining social media use By Michael Miller, 513-556-6757, michael.miller3@uc.edu Inside HIgher Education highlighted a new study by researchers at the University of Cincinnati that found students who spent more time on social media reported more feelings of loneliness. The study, published in the Journal of America more PR

RENO, Nevada, Feb. 19 -- The University of Nevada issued the following news: * * * Department of Energy awards $9 million for national research project on cactus pear's bioenergy potential University of Nevada, Reno researchers will lead the multistate five-year project Emma Lande As the quest to diversify and expand sustainable alternative energy products continues, the U.S. Department of Energy has awarded a $9 million grant to support research that will be led by researchers at the Univ more PR

MILWAUKEE, Wisconsin, Feb. 19 (TNSjou) -- The University of Wisconsin Milwaukee campus issued the following news release: * * * Reminding people they're talking to chatbots may be ineffective or even harmful, researchers say Concerns that chatbot use can cause mental and physical harm have prompted policies that require AI chatbots to deliver regular or constant reminders that they are not human. In an opinion paper published Feb. 18 in the Cell Press journal Trends in Cognitive Sciences, a U more PR

LONDON, England, Feb. 19 (TNSjou) -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release: * * * ViiV Healthcare's long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM - Final data from LATITUDE study show switch to long-acting injectable treatment reduced the risk of virological failure by nearly half for study participan more PR